Magazine
Oncology / Hematology • No. 17 • 2024
- Second-Line Treatment of mRCC – Data Support the Choice of Cabozantinib Monotherapy
- ESMO 2024 – Highlights
- EHA 2024 – A Danish Late-Breaking Abstract Presented
EHA | Congress
We cover the most interesting news from the EHA Congress through abstracts, online articles and MEDtalk videos from experts and specialists worldwide.
Go to pageArticles
MEDtalks
Nordic advisory editorial board*
*BestPractice Nordic maintains a continuous dialogue with the Nordic Advisory Editorial Panel. This panel aids in proposing editorial themes, bringing attention to new guidelines, essays, relevant clinical issues, and updates from national and international congresses. Please note that the advisory editorial panel is NOT accountable for the content published by BestPractice Nordic. All content undergoes approval by the author.
